Anitha Varghese
Imperial College London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anitha Varghese.
Journal of Magnetic Resonance Imaging | 2003
Lindsey A. Crowe; Peter D. Gatehouse; Guang-Zhong Yang; Raad H. Mohiaddin; Anitha Varghese; Clare L. Charrier; Jennifer Keegan; David N. Firmin
To use a volume‐selective 3D turbo spin echo (TSE) technique to image the carotid artery wall and measure distensibility.
Journal of Magnetic Resonance Imaging | 2005
Anitha Varghese; Lindsey A. Crowe; Raad H. Mohiaddin; Peter D. Gatehouse; Guang-Zhong Yang; David M. Nott; James M. McCall; David N. Firmin; Dudley J. Pennell
To assess the interstudy reproducibility of a three‐dimensional volume‐selective, fast spin echo (FSE) magnetic resonance technique for the assessment of carotid artery wall volume, which is a marker for total carotid plaque volume.
Journal of Magnetic Resonance Imaging | 2005
Lindsey A. Crowe; Jennifer Keegan; Peter D. Gatehouse; Raad H. Mohiaddin; Anitha Varghese; Karen Symmonds; Timothy M. Cannell; Guang-Zhong Yang; David N. Firmin
To improve 3D volume‐selective turbo spin echo (TSE) carotid artery wall imaging by incorporating navigators to reduce artifacts caused by swallowing.
Journal of Magnetic Resonance Imaging | 2006
Lindsey A. Crowe; Anitha Varghese; Raad H. Mohiaddin; Guang-Zhong Yang; David N. Firmin
To improve 3D volume‐selective turbo spin–echo (TSE) arterial wall imaging by introducing velocity phase sensitivity to the sequence.
Journal of Cardiovascular Magnetic Resonance | 2004
Raad H. Mohiaddin; Elisabeth D. Burman; S. K. Prasad; Anitha Varghese; R. S. Tan; S. A. Collins; R. L. Hughes; Peter D. Gatehouse; P. Jhooti; D. B. Longmore; Guang Z. Yang; David N. Firmin; Dudley J. Pennell
BACKGROUND Aortic atherosclerosis and coronary artery disease (CAD) are closely linked. Early detection of aortic atherosclerosis with the adoption of appropriate preventive measures may therefore help to reduce mortality and morbidity related to CAD. Arterial remodeling, by which the wall adapts to physiological or pathological insults by a change in vessel size, is being increasingly recognized as an important aspect of atherosclerosis. In this prospective longitudinal study we used cardiovascular magnetic resonance (CMR) to detect aortic plaque and to study aortic wall remodeling in asymptomatic subjects. METHODS We recruited 175 healthy volunteers (49 years, 110 men) and documented their cardiovascular risk profile. Each subject underwent echocardiogram (ECG)-gated T1-weighted spin-echo imaging of the infrarenal abdominal aorta at baseline and after 2 years. FINDINGS Of the 175 subjects who volunteered at baseline, CMR was successful in 174 (99%), with one (0.6%) failure due to claustrophobia. At 2 years, follow-up scanning was performed in 169 subjects (97%). Infrarenal aortic plaque was identified at baseline in nine (5.2%) subjects. This was reconfirmed in all nine (100%) cases at 2-year follow-up. No new cases of infrarenal plaque were identified at follow-up. The signal characteristics of the plaque on the subtracted images of the Dixon method indicate that all plaques were fibrous. In the nine subjects with infrarenal plaque, the total plaque burden increased as assessed by the total wall volume (561 to 677 mm3, p = 0.0063). The total vessel volume also increased (1737 to 1835 mm3, p = 0.031) but there was no change in the total luminal volume (1175 to 1157 mm3, p = 0.29). CONCLUSIONS Cardiovascular magnetic resonance detects subclinical aortic atherosclerosis, can follow plaque burden over time, and confirms the presence of Glagov remodeling with preservation of the lumen despite progression of plaque. Cardiovascular magnetic resonance is well suited for the longitudinal follow-up of the general population with atherosclerosis, may help in the understanding of the natural history of atherosclerosis, and in particular may help determine factors to retard disease progression at an early stage.
Circulation | 2002
Anitha Varghese; Michael A. Gatzoulis; Raad H. Mohiaddin
A 26-year-old man presented with sudden onset headache, loss of consciousness, neck stiffness, and visual impairment. An urgent computed tomographic scan showed a diffuse subarachnoid hemorrhage, which was treated with a right frontal craniotomy and clipping of a right anterior communicating artery aneurysm (Figure 1). An arch aortogram performed during the preoperative neurosurgical evaluation revealed a complete interruption of the aortic arch just distal to the origin of the left subclavian artery …
Journal of Cardiovascular Magnetic Resonance | 2009
Anitha Varghese; Michael S. Yee; Cheuk F Chan; Lindsey A. Crowe; Niall G. Keenan; Desmond G. Johnston; Dudley J. Pennell
BackgroundThere is recent evidence suggesting that rosiglitazone increases death from cardiovascular causes. We investigated the direct effect of this drug on atheroma using 3D carotid cardiovascular magnetic resonance.ResultsA randomized, placebo-controlled, double-blind study was performed to evaluate the effect of rosiglitazone treatment on carotid atherosclerosis in subjects with type 2 diabetes and coexisting vascular disease or hypertension. The primary endpoint of the study was the change from baseline to 52 weeks of carotid arterial wall volume, reflecting plaque burden, as measured by carotid cardiovascular magnetic resonance. Rosiglitazone or placebo was allocated to 28 and 29 patients respectively. Patients were managed to have equivalent glycemic control over the study period, but in fact the rosiglitazone group lowered their HbA1c by 0.88% relative to placebo (P < 0.001). Most patients received a statin or fibrate as lipid control medication (rosiglitazone 78%, controls 83%). Data are presented as mean ± SD. At baseline, the carotid arterial wall volume in the placebo group was 1146 ± 550 mm3 and in the rosiglitazone group was 1354 ± 532 mm3. After 52 weeks, the respective volumes were 1134 ± 523 mm3 and 1348 ± 531 mm3. These changes (-12.1 mm3 and -5.7 mm3 in the placebo and rosiglitazone groups, respectively) were not statistically significant between groups (P = 0.57).ConclusionTreatment with rosiglitazone over 1 year had no effect on progression of carotid atheroma in patients with type 2 diabetes mellitus compared to placebo.
Journal of Magnetic Resonance Imaging | 2006
Anitha Varghese; Robert Merrifield; Lindsey A. Crowe; Steven Collins; Niall G. Keenan; David N. Firmin; Guang-Zhong Yang; Dudley J. Pennell
To evaluate semiautomated analysis software for measuring the total carotid arterial wall volume (TWV) as a measure of atheroma burden.
Atherosclerosis | 2009
Niall G. Keenan; Didier Locca; Anitha Varghese; Michael Roughton; Peter D. Gatehouse; James Hooper; David N. Firmin; Dudley J. Pennell
OBJECTIVE To assess how the arterial wall of the carotid artery changes with age in normal subjects by cardiovascular magnetic resonance (CMR). METHODS Carotid CMR was performed in 100 normal subjects (10 per sex per decade) who were free of atherosclerotic risk factors and carotid atherosclerosis. Using three-dimensional computer modeling, the volumes of the arterial wall, lumen, and the total vessel were calculated, and the wall/outer wall (W/OW) ratio was derived. RESULTS Wall volume and total vessel volume increased significantly with age in both sexes (p<0.006), and this was more marked in males. The W/OW ratio also increased significantly with age (p<0.001). Lumen volume increased significantly with age in males (p<0.001), but not in females (p=0.1). CONCLUSIONS In normal subjects, carotid wall volume increases with age. In men, this vessel wall volume increase is associated with significant remodeling of the lumen and outer wall. These data relating normal carotid findings with ageing are important for further CMR studies of early atherosclerosis.
Coronary Artery Disease | 2005
Anitha Varghese; Jennifer Keegan; Dudley J. Pennell
Cardiovascular magnetic resonance of anomalous coronary arteries is a class I indication. The term anomalous coronary artery encompasses those with an abnormal origin (from the incorrect sinus, too-high or too-low from the correct sinus, or from the pulmonary artery) and/or number of ostia. Their clinical significance results from the increased risk of myocardial infarction and sudden cardiac death associated with those traversing an interarterial course between the aorta and main pulmonary artery/right ventricular outflow tract. In this article, we review the role and practice of cardiovascular magnetic resonance in this field.